ARTICLE | Company News
ViroPharma sales and marketing update
October 31, 2011 7:00 AM UTC
ViroPharma reported in its 3Q11 earnings that it launched hereditary angioedema (HAE) drug Cinryze in Germany late last quarter. The company plans to launch the complement 1 (C1) esterase inhibitor ...